Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News BioNxt Solutions Inc C.BNXT

Alternate Symbol(s):  BNXTF

Healthcare
BioNxt Solutions Inc. is a bioscience company. The Company is focused on drug formulations and delivery systems, diagnostic screening tests, and new active pharmaceutical ingredient investment opportunities, including precision transdermal and oral dissolvable drug formulations; rapid, low-cost infectious disease and oral health screening tests; and standardization of emerging active... see more

Recent & Breaking News (CSE:BNXT)

XPhyto Therapeutics Closes Private Placements for Gross Proceeds of $7,000,0000

Accesswire November 26, 2021

XPhyto Announces CFO Appointment

Accesswire November 19, 2021

XPhyto Announces Managing Director Appointment, Financing and 3a-diagnostics Development

Accesswire November 3, 2021

XPhyto Reports Development Update for its Drug Delivery Business

Accesswire October 12, 2021

Xphyto Announces Engagement of Consultants for Marketing and Promotional Activities

Accesswire October 8, 2021

XPhyto Reports Successful Market Launch and Growing Demand for its 25-minute COVID-19 PCR Test COVID-ID Lab

Accesswire September 8, 2021

XPhyto Launches First Commercial Biosensor for Oral Disease

Accesswire August 30, 2021

XPhyto's Acquisition Target, 3a-Diagnostics, Reports Breakthrough Identification of COVID-19 Biosensor Candidates

Accesswire July 28, 2021

XPhyto Signs Transformative Acquisition Agreement With 3a-Diagnostics, to Enter Hi-Tech Biosensor Market and Expand Its Diagnostic Product Portfolio

Accesswire July 20, 2021

XPhyto Announces Advertising Agreement with Agora Internet Relations Corp.

Accesswire July 2, 2021

XPhyto Supplies 10 Test Centers in Berlin with 25-minute COVID-19 PCR Test

Accesswire June 30, 2021

InvestorBrandNetwork (IBN) Announces Latest Episode of The Bell2Bell Podcast featuring Hugh Rogers, CEO of XPhyto Therapeutics Corp.

GlobeNewswire June 17, 2021

XPhyto Therapeutics (CSE:XPHY) featured in mescaline program progress report

John Ballem  June 15, 2021

XPhyto Therapeutics Corp. Featured in Syndicated Broadcast Covering Latest Progress Report on Mescaline Program for Psychedelic Therapies

GlobeNewswire June 15, 2021

XPhyto Provides Progress Report on Mescaline Program for Psychedelic Therapies

Accesswire June 8, 2021

XPhyto Rapid Point-of-Care COVID-19 PCR Test Offered for Sale in Germany

Accesswire May 20, 2021

XPhyto Provides Update on Drug Formulation and Development Business

Accesswire May 13, 2021

XPhyto Establishes Proof of Concept Station for Point-of-Care 25-minute COVID-19 PCR Test in Germany

Accesswire May 7, 2021

InvestorBrandNetwork Announces Gamechangers LIVE Interview with XPhyto Therapeutics Corp. CEO and Director Hugh Rogers

GlobeNewswire May 6, 2021

XPhyto Pursues Market Access in Israel for its COVID-19 PCR Rapid Test

Accesswire April 28, 2021